 Why Clinical Laboratories are at a Crossroads. Since 2022, more than 40% of independent labs have shut their doors, according to Lighthouse Lab Services’ recent analysis of CLIA and CMS data. Many of these closures stem from a lack of preparedness or reliance on outdated operating models. The result has been an industry shake-out that few are openly discussing. Yet within this disruption lies opportunity. As Jon Harol, Founder of Lighthouse Lab Services, explains, “The herd has been thinned. But the labs that adapt and prepare are the ones that continue to grow.” Consolidation means that while fewer labs remain, the demand for testing hasn’t disappeared, these sample volumes still need to be processed. For the organizations prepared to adapt, this moment represents a chance to capture more volume and expand their market position. Meeting Lab Owners Where They Are Lighthouse began in 2003 as a staffing and recruiting firm, created in response to widespread shortages of medical laboratory professionals. Over time, the company expanded its services based on client demand—adding part-time and full-time lab directors, PhD-level expertise for LDT validations and lab design, revenue cycle management, field service engineering, and even payer network access support. Harol describes the philosophy as simple: listen and respond. “We’ve always grown by asking what our clients need next and figuring out how to provide it,” he says. That approach has positioned Lighthouse as a multi-stop partner for more than 200 high-complexity CLIA labs across the country Tackling the Workforce Crisis  Despite industry shifts, staffing remains a perennial challenge. Lighthouse’s Wage & Morale Report underscores what many already know: labs are struggling to attract and retain qualified professionals. The difference, Harol notes, is in how leaders approach the problem. “The best labs play the long game. They invest in their culture because good culture attracts and retains talent.” Rather than relying solely on stopgap solutions like temporary workers, he encourages lab managers to focus on morale, team development, and flexibility. Even small changes, such as offering occasional remote work days for tasks like QC or paperwork, can have an outsized impact. “That kind of work-life balance often means more to employees than a pay bump,” Harol adds. Turning Compliance and Reimbursement Into Strengths For many lab managers, compliance oversight and reimbursement pressure feel like constant vulnerabilities. Harol sees it differently. With the right strategies, these areas can become competitive strengths. One key is being selective about sample volume. “We see labs chasing growth by bringing in as many samples as possible, but 40% of that work can end up unpaid,” he explains. Instead, successful labs ensure they’re targeting the right samples, those that drive revenue rather than drain resources. On the compliance side, Harol emphasizes that regulations, when taken seriously, can improve efficiency. Cutting corners often leads to wasted time and risk exposure. “Haste makes waste,” he says. Recent CLIA crackdowns on workforce credentialing are a case in point. While some push back at the added paperwork, Harol believes these checks ultimately strengthen labs and improve patient outcomes.  Busting Myths About Lab-Developed Tests Another area where Harol sees misunderstanding is in the perception of lab-developed tests (LDTs). “There’s no data showing that LDTs are driving bad results,” he points out. In fact, most errors occur in FDA-approved tests. Rather than vilifying LDTs, Harol argues, the real need is to modernize CLIA, which hasn’t been updated since 1988. With AI algorithms now producing lab results and digital samples flowing between laboratories, outdated regulations risk falling behind reality. “These are the areas we should focus on if we want to ensure quality testing for the future,” he says. Positioning Labs for the Future Looking ahead, Harol sees major changes on the horizon, not just for labs, but for healthcare overall. The shift from fee-for-service to value-based care will reward outcomes and preventative measures over volume alone. That puts labs in a powerful position. Despite accounting for just 2.6% of healthcare spend, laboratory testing informs 70% of medical decisions. “We are the best dollar you can spend in healthcare,” Harol says. “The labs that position themselves as partners in value-based care will thrive.” Final Takeaway Preparedness is no longer optional for clinical labs. Whether it’s building strong cultures, making strategic decisions about reimbursement, or modernizing compliance processes, resilience depends on a willingness to adapt. For Harol, the message is clear: “The labs that think long-term, invest in their people, and align with where healthcare is heading will not only survive—but grow stronger in the process.” This blog was compiled from key insights shared by Jon Harol, Founder of Lighthouse Lab Services, during his recent interview on Life Sciences Decoded. You can watch the full conversation here: https://youtu.be/BcPSO2hewgg
0 Comments
Leave a Reply. |
Authors
Meghan O'Sullivan
Susan Najjar
|
